Short Interest in Adlai Nortye Ltd. Sponsored ADR (NASDAQ:ANL) Rises By 458.7%

Adlai Nortye Ltd. Sponsored ADR (NASDAQ:ANLGet Free Report) saw a large increase in short interest during the month of January. As of January 30th, there was short interest totaling 757,655 shares, an increase of 458.7% from the January 15th total of 135,611 shares. Currently, 2.1% of the shares of the company are short sold. Based on an average daily trading volume, of 1,844,236 shares, the days-to-cover ratio is currently 0.4 days. Based on an average daily trading volume, of 1,844,236 shares, the days-to-cover ratio is currently 0.4 days. Currently, 2.1% of the shares of the company are short sold.

Adlai Nortye Price Performance

Adlai Nortye stock opened at $9.74 on Wednesday. Adlai Nortye has a one year low of $0.88 and a one year high of $12.09. The business has a fifty day moving average of $3.09 and a two-hundred day moving average of $2.14.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of Adlai Nortye in a research note on Wednesday, January 21st. One investment analyst has rated the stock with a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the stock has an average rating of “Reduce”.

View Our Latest Research Report on Adlai Nortye

Adlai Nortye Company Profile

(Get Free Report)

Adlai Nortye Inc (NASDAQ: ANL) is a specialty chemical manufacturer headquartered in China’s Jiangsu Province. The company focuses on the research, development, production and sale of fine chemicals, with a primary emphasis on amino acids and their derivatives.

Adlai Nortye’s product portfolio includes betaine compounds, a range of high-purity L-amino acids such as L-methionine, L-threonine and glycine, as well as various chemical intermediates. These offerings serve multiple end markets, including animal feed and nutrition, personal care and cosmetic formulations, pharmaceutical ingredients and industrial chemical processes.

The company operates multiple production facilities alongside an in-house research and development center dedicated to process innovation and quality control.

Further Reading

Receive News & Ratings for Adlai Nortye Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adlai Nortye and related companies with MarketBeat.com's FREE daily email newsletter.